Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 23 hours agoWith a valuation of US$47 billion (~A$71 billion), Moderna aims to leverage AI to automate functions...
'Fighting for Approval': Barriers to Needed Medications
Medscape· 6 days agoTherapies such as growth hormones and puberty blockers often face shortages, leaving pediatric...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 6 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agos first-quarter 2024 financial results and business updates. You can access the press release issued this morning as well as the slides that we'll be...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
WFRV 5 Green Bay· 7 days agoUSA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer ...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 6 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 6 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...